Molecular Logic Underlying Chromosomal Translocations, Random or Non-Random?

Advances in Cancer Research

Volumn 113, Issue , 2012, Pages 241-279

  Lin, Chunru ^a,b   Yang, Liuqing ^a,b   Rosenfeld, Michael G ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Chromosomal Translocation; DNA double stranded Break; Epigenetic Strategies; Non random; Spatial Proximity; Transcription

Indexed keywords

DEOXYRIBONUCLEASE; DOUBLE STRANDED DNA; IMATINIB; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; REACTIVE OXYGEN METABOLITE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR ERG; TRANSCRIPTION FACTOR ETV6;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER GENETICS; CARCINOGENESIS; CELL STRESS; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME 13Q; CHROMOSOME 8P; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; DNA METHYLATION; DOUBLE STRANDED DNA BREAK; EPIGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FUSION; GENETIC ASSOCIATION; GENETIC DISTANCE; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; INTRACELLULAR SIGNALING; LUNG NON SMALL CELL CANCER; MOLECULAR GENETICS; MOLECULAR MODEL; NONHUMAN; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROSTATE CANCER; RECIPROCAL CHROMOSOME TRANSLOCATION; TRANSPOSON;

EID: 84863342268     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394280-7.00015-4     Document Type: Chapter

References (226)

1. Aghib D.F., Bishop J.M., Ottolenghi S., Guerrasio A., Serra A., Saglio G. A 3' truncation of MYC caused by chromosomal translocation in a human T-cell leukemia increases mRNA stability. Oncogene 1990, 5:707-711.
2. Aguilera A. The connection between transcription and genomic instability. EMBO J. 2002, 21:195-201.
3. Aguilera A. mRNA processing and genomic instability. Nat. Struct. Mol. Biol. 2005, 12:737-738.
4. Aplan P.D. Causes of oncogenic chromosomal translocation. Trends Genet. 2006, 22:46-55.
5. Aryee D.N., Kreppel M., Bachmaier R., Uren A., Muehlbacher K., Wagner S., Breiteneder H., Ban J., Toretsky J.A., Kovar H. Single-chain antibodies to the EWS NH(2) terminus structurally discriminate between intact and chimeric EWS in Ewing's sarcoma and interfere with the transcriptional activity of EWS in vivo. Cancer Res. 2006, 66:9862-9869.
6. Asakawa J., Kuick R., Kodaira M., Nakamura N., Katayama H., Pierce D., Funamoto S., Preston D., Satoh C., Neel J.V., et al. A genome scanning approach to assess the genetic effects of radiation in mice and humans. Radiat. Res. 2004, 161:380-390.
7. Asatiani E., Huang W.X., Wang A., Rodriguez Ortner E., Cavalli L.R., Haddad B.R., Gelmann E.P. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res. 2005, 65:1164-1173.
8. Asmann Y.W., Hossain A., Necela B.M., Middha S., Kalari K.R., Sun Z., Chai H.S., Williamson D.W., Radisky D., Schroth G.P., et al. A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines. Nucleic Acids Res. 2011, 39:e100.
9. Attard G., Clark J., Ambroisine L., Mills I.G., Fisher G., Flohr P., Reid A., Edwards S., Kovacs G., Berney D., et al. Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. Br. J. Cancer 2008, 99:314-320.
10. Bartek J., Hamerlik P., Lukas J. On the origin of prostate fusion oncogenes. Nat. Genet. 2010, 42:647-648.
11. Bartova E., Krejci J., Harnicarova A., Galiova G., Kozubek S. Histone modifications and nuclear architecture: a review. J. Histochem. Cytochem. 2008, 56:711-721.
12. Barwick B.G., Abramovitz M., Kodani M., Moreno C.S., Nam R., Tang W., Bouzyk M., Seth A., Leyland-Jones B. Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts. Br. J. Cancer 2010, 102:570-576.
13. Bastus N.C., Boyd L.K., Mao X., Stankiewicz E., Kudahetti S.C., Oliver R.T., Berney D.M., Lu Y.J. Androgen-induced TMPRSS2:ERG fusion in nonmalignant prostate epithelial cells. Cancer Res. 2010, 70:9544-9548.
14. Batra V., Kesavan V., Mishra K.P. Modulation of enzymes involved in folate dependent one-carbon metabolism by gamma-radiation stress in mice. J. Radiat. Res. (Tokyo) 2004, 45:527-533.
15. Belancio V.P., Deininger P.L., Roy-Engel A.M. LINE dancing in the human genome: transposable elements and disease. Genome Med. 2009, 1:97.
16. Belancio V.P., Roy-Engel A.M., Pochampally R.R., Deininger P. Somatic expression of LINE-1 elements in human tissues. Nucleic Acids Res. 2010, 38:3909-3922.
17. Beletskii A., Bhagwat A.S. Transcription-induced mutations: increase in C to T mutations in the nontranscribed strand during transcription in Escherichia coli. Proc. Natl. Acad. Sci. USA 1996, 93:13919-13924.
18. Boboila C., Jankovic M., Yan C.T., Wang J.H., Wesemann D.R., Zhang T., Fazeli A., Feldman L., Nussenzweig A., Nussenzweig M., et al. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc. Natl. Acad. Sci. USA 2010, 107:3034-3039.
19. Boehm T., Mengle-Gaw L., Kees U.R., Spurr N., Lavenir I., Forster A., Rabbitts T.H. Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours. EMBO J. 1989, 8:2621-2631.
20. Branzei D., Foiani M. The DNA damage response during DNA replication. Curr. Opin. Cell Biol. 2005, 17:568-575.
21. Brill S.J., DiNardo S., Voelkel-Meiman K., Sternglanz R. DNA topoisomerase activity is required as a swivel for DNA replication and for ribosomal RNA transcription. NCI Monogr. 1987, (4):11-15.
22. Brock R.D. Differential mutation of the beta-galactosidase gene of Escherichia coli. Mutat. Res. 1971, 11:181-186.
23. Burhans W.C., Weinberger M. DNA replication stress, genome instability and aging. Nucleic Acids Res. 2007, 35:7545-7556.
24. Cairns P., Polascik T.J., Eby Y., Tokino K., Califano J., Merlo A., Mao L., Herath J., Jenkins R., Westra W., et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet. 1995, 11:210-212.
25. Carter M.T., Barrowman N.J., St Pierre S.A., Emanuel B.S., Boycott K.M. Risk of breast cancer not increased in translocation 11;22 carriers: analysis of 80 pedigrees. Am. J. Med. Genet. A 2010, 152A:212-214.
26. Caudill C.M., Zhu Z., Ciampi R., Stringer J.R., Nikiforov Y.E. Dose-dependent generation of RET/PTC in human thyroid cells after in vitro exposure to gamma-radiation: a model of carcinogenic chromosomal rearrangement induced by ionizing radiation. J. Clin. Endocrinol. Metab. 2005, 90:2364-2369.
27. Chakalova L., Fraser P. Organization of transcription. Cold Spring Harb. Perspect. Biol. 2010, 2:a000729.
28. Chaudhuri J., Alt F.W. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 2004, 4:541-552.
29. Chaudhuri J., Khuong C., Alt F.W. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 2004, 430:992-998.
30. Chi P., Allis C.D., Wang G.G. Covalent histone modifications-miswritten, misinterpreted and mis-erased in human cancers. Nat. Rev. Cancer 2010, 10:457-469.
31. Chiarle R., Zhang Y., Frock R.L., Lewis S.M., Molinie B., Ho Y.J., Myers D.R., Choi V.W., Compagno M., Malkin D.J., et al. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 2011, 147:107-119.
32. Christman M.F., Dietrich F.S., Fink G.R. Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and II. Cell 1988, 55:413-425.
33. Collier L.S., Largaespada D.A. Transposable elements and the dynamic somatic genome. Genome Biol. 2007, 8(Suppl. 1):S5.
34. Cooke M.S., Evans M.D., Dizdaroglu M., Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003, 17:1195-1214.
35. Cope N.F., Fraser P., Eskiw C.H. The yin and yang of chromatin spatial organization. Genome Biol. 2010, 11:204.
36. Cox C., Bignell G., Greenman C., Stabenau A., Warren W., Stephens P., Davies H., Watt S., Teague J., Edkins S., et al. A survey of homozygous deletions in human cancer genomes. Proc. Natl. Acad. Sci. USA 2005, 102:4542-4547.
37. Cremer T., Cremer C. Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat. Rev. Genet. 2001, 2:292-301.
38. Datta A., Jinks-Robertson S. Association of increased spontaneous mutation rates with high levels of transcription in yeast. Science 1995, 268:1616-1619.
39. Deininger M., Buchdunger E., Druker B.J. The development of imatinib as a therapeutic agent for chronic myeloid leukemia. Blood 2005, 105:2640-2653.
40. Deininger M.W., Bose S., Gora-Tybor J., Yan X.H., Goldman J.M., Melo J.V. Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation. Cancer Res. 1998, 58:421-425.
41. Di Noia J., Neuberger M.S. Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 2002, 419:43-48.
42. Epstein C.J. Down's syndrome: critical genes in a critical region. Nature 2006, 441:582-583.
43. Ergun S., Buschmann C., Heukeshoven J., Dammann K., Schnieders F., Lauke H., Chalajour F., Kilic N., Stratling W.H., Schumann G.G. Cell type-specific expression of LINE-1 open reading frames 1 and 2 in fetal and adult human tissues. J. Biol. Chem. 2004, 279:27753-27763.
44. Eskiw C.H., Cope N.F., Clay I., Schoenfelder S., Nagano T., Fraser P. Transcription factories and nuclear organization of the genome. Cold Spring Harb. Symp. Quant. Biol. 2010, 75:501-506.
45. Fanning E., Klimovich V., Nager A.R. A dynamic model for replication protein A (RPA) function in DNA processing pathways. Nucleic Acids Res. 2006, 34:4126-4137.
46. Feng Q., Moran J.V., Kazazian H.H., Boeke J.D. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 1996, 87:905-916.
47. Ferguson D.O., Alt F.W. DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene 2001, 20:5572-5579.
48. Fix D.F., Glickman B.W. Asymmetric cytosine deamination revealed by spontaneous mutational specificity in an Ung- strain of Escherichia coli. Mol. Gen. Genet. 1987, 209:78-82.
49. Florl A.R., Lower R., Schmitz-Drager B.J., Schulz W.A. DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas. Br. J. Cancer 1999, 80:1312-1321.
50. Fraser P. Transcriptional control thrown for a loop. Curr. Opin. Genet. Dev. 2006, 16:490-495.
51. Fraser P., Engel J.D. Constricting restricted transcription: the (actively?) shrinking web. Genes Dev. 2006, 20:1379-1383.
52. Frederico L.A., Kunkel T.A., Shaw B.R. A sensitive genetic assay for the detection of cytosine deamination: determination of rate constants and the activation energy. Biochemistry 1990, 29:2532-2537.
53. Fukukawa C., Nakamura Y., Katagiri T. Molecular target therapy for synovial sarcoma. Future Oncol. 2005, 1:805-812.
54. Gambacorti-Passerini C. Part I: milestones in personalised medicine-imatinib. Lancet Oncol. 2008, 9:600.
55. Gapud E.J., Dorsett Y., Yin B., Callen E., Bredemeyer A., Mahowald G.K., Omi K.Q., Walker L.M., Bednarski J.J., McKinnon P.J., et al. Ataxia telangiectasia mutated (Atm) and DNA-PKcs kinases have overlapping activities during chromosomal signal joint formation. Proc. Natl. Acad. Sci. USA 2011, 108:2022-2027.
56. Gaymes T.J., North P.S., Brady N., Hickson I.D., Mufti G.J., Rassool F.V. Increased error-prone non homologous DNA end-joining-a proposed mechanism of chromosomal instability in Bloom's syndrome. Oncogene 2002, 21:2525-2533.
57. Gnatt A.L., Cramer P., Fu J., Bushnell D.A., Kornberg R.D. Structural basis of transcription: an RNA polymerase II elongation complex at 3.3 å resolution. Science 2001, 292:1876-1882.
58. Gostissa M., Alt F.W., Chiarle R. Mechanisms that promote and suppress chromosomal translocations in lymphocytes. Annu. Rev. Immunol. 2011, 29:319-350.
59. Graziano F., Kawakami K., Ruzzo A., Watanabe G., Santini D., Pizzagalli F., Bisonni R., Mari D., Floriani I., Catalano V., et al. Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population. Int. J. Cancer 2006, 118:628-632.
60. Haffner M.C., Aryee M.J., Toubaji A., Esopi D.M., Albadine R., Gurel B., Isaacs W.B., Bova G.S., Liu W., Xu J., et al. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat. Genet. 2010, 42:668-675.
61. Hagan C.R., Sheffield R.F., Rudin C.M. Human Alu element retrotransposition induced by genotoxic stress. Nat. Genet. 2003, 35:219-220.
62. Handler A.M., Gomez S.P. A new hobo, Ac, Tam3 transposable element, hopper, from Bactrocera dorsalis is distantly related to hobo and Ac. Gene 1997, 185:133-135.
63. Hansmann I., Wiedeking C., Grimm T., Gebauer J. Reciprocal or nonreciprocal human chromosome translocations? The identification of reciprocal translocations by silver staining. Hum. Genet. 1977, 38:1-5.
64. Harismendy O., Notani D., Song X., Rahim N.G., Tanasa B., Heintzman N., Ren B., Fu X.D., Topol E.J., Rosenfeld M.G., et al. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 2011, 470:264-268.
65. Hata K., Sakaki Y. Identification of critical CpG sites for repression of L1 transcription by DNA methylation. Gene 1997, 189:227-234.
66. Helgason G.V., Karvela M., Holyoake T.L. Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML. Blood 2011, 118:2035-2043.
67. Hollander M.C., Blumenthal G.M., Dennis P.A. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat. Rev. Cancer 2011, 11:289-301.
68. Hu Q., Kwon Y.S., Nunez E., Cardamone M.D., Hutt K.R., Ohgi K.A., Garcia-Bassets I., Rose D.W., Glass C.K., Rosenfeld M.G., et al. Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc. Natl. Acad. Sci. USA 2008, 105:19199-19204.
69. Huang G.S., Keil R.L. Requirements for activity of the yeast mitotic recombination hotspot HOT1: RNA polymerase I and multiple cis-acting sequences. Genetics 1995, 141:845-855.
70. Huang M.E., Kolodner R.D. A biological network in Saccharomyces cerevisiae prevents the deleterious effects of endogenous oxidative DNA damage. Mol. Cell 2005, 17:709-720.
71. Ichijima Y., Yoshioka K., Yoshioka Y., Shinohe K., Fujimori H., Unno J., Takagi M., Goto H., Inagaki M., Mizutani S., et al. DNA lesions induced by replication stress trigger mitotic aberration and tetraploidy development. PLoS One 2010, 5:e8821.
72. Ikeda H., Matsumoto T. Transcription promotes recA-independent recombination mediated by DNA-dependent RNA polymerase in Escherichia coli. Proc. Natl. Acad. Sci. USA 1979, 76:4571-4575.
73. Iljin K., Wolf M., Edgren H., Gupta S., Kilpinen S., Skotheim R.I., Peltola M., Smit F., Verhaegh G., Schalken J., et al. TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming. Cancer Res. 2006, 66:10242-10246.
74. Izsvak Z., Ivics Z. Sleeping beauty transposition: biology and applications for molecular therapy. Mol. Ther. 2004, 9:147-156.
75. Jankovic M., Nussenzweig A., Nussenzweig M.C. Antigen receptor diversification and chromosome translocations. Nat. Immunol. 2007, 8:801-808.
76. Ji Y., Resch W., Corbett E., Yamane A., Casellas R., Schatz D.G. The in vivo pattern of binding of RAG1 and RAG2 to antigen receptor loci. Cell 2010, 141:419-431.
77. Jones P.A., Gonzalgo M.L. Altered DNA methylation and genome instability: a new pathway to cancer?. Proc. Natl. Acad. Sci. USA 1997, 94:2103-2105.
78. Ju B.G., Lunyak V.V., Perissi V., Garcia-Bassets I., Rose D.W., Glass C.K., Rosenfeld M.G. A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription. Science 2006, 312:1798-1802.
79. Jung D., Alt F.W. Unraveling V(D)J recombination; insights into gene regulation. Cell 2004, 116:299-311.
80. Kadesch T.R., Chamberlin M.J. Studies of in vitro transcription by calf thymus RNA polymerase II using a novel duplex DNA template. J. Biol. Chem. 1982, 257:5286-5295.
81. Karanjawala Z.E., Grawunder U., Hsieh C.L., Lieber M.R. The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts. Curr. Biol. 1999, 9:1501-1504.
82. Kazazian H.H. Mobile elements: drivers of genome evolution. Science 2004, 303:1626-1632.
83. Kearney L., Horsley S.W. Molecular cytogenetics in haematological malignancy: current technology and future prospects. Chromosoma 2005, 114:286-294.
84. Kettenberger H., Armache K.J., Cramer P. Complete RNA polymerase II elongation complex structure and its interactions with NTP and TFIIS. Mol. Cell 2004, 16:955-965.
85. Klein I.A., Resch W., Jankovic M., Oliveira T., Yamane A., Nakahashi H., Di Virgilio M., Bothmer A., Nussenzweig A., Robbiani D.F., et al. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 2011, 147:95-106.
86. Koivisto P., Kononen J., Palmberg C., Tammela T., Hyytinen E., Isola J., Trapman J., Cleutjens K., Noordzij A., Visakorpi T., et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res. 1997, 57:314-319.
87. Konkel M.K., Batzer M.A. A mobile threat to genome stability: the impact of non-LTR retrotransposons upon the human genome. Semin. Cancer Biol. 2010, 20:211-221.
88. Korsmeyer S.J. Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu. Rev. Immunol. 1992, 10:785-807.
89. Kosak S.T., Skok J.A., Medina K.L., Riblet R., Le Beau M.M., Fisher A.G., Singh H. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 2002, 296:158-162.
90. Kumar-Sinha C., Tomlins S.A., Chinnaiyan A.M. Recurrent gene fusions in prostate cancer. Nat. Rev. Cancer 2008, 8:497-511.
91. Kuppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 2005, 5:251-262.
92. Kuppers R., Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 2001, 20:5580-5594.
93. Kuramoto K., Ban S., Oda K., Tanaka H., Kimura A., Suzuki G. Chromosomal instability and radiosensitivity in myelodysplastic syndrome cells. Leukemia 2002, 16:2253-2258.
94. Lamb N.E., Yu K., Shaffer J., Feingold E., Sherman S.L. Association between maternal age and meiotic recombination for trisomy 21. Am. J. Hum. Genet. 2005, 76:91-99.
95. Lanctot C., Cheutin T., Cremer M., Cavalli G., Cremer T. Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions. Nat. Rev. Genet. 2007, 8:104-115.
96. Lavin M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 2008, 9:759-769.
97. Leder P., Battey J., Lenoir G., Moulding C., Murphy W., Potter H., Stewart T., Taub R. Translocations among antibody genes in human cancer. Science 1983, 222:765-771.
98. Lee K., Zhang Y., Lee S.E. Saccharomyces cerevisiae ATM orthologue suppresses break-induced chromosome translocations. Nature 2008, 454:543-546.
99. Lengauer C., Kinzler K.W., Vogelstein B. DNA methylation and genetic instability in colorectal cancer cells. Proc. Natl. Acad. Sci. USA 1997, 94:2545-2550.
100. Li C., Larsson C., Futreal A., Lancaster J., Phelan C., Aspenblad U., Sundelin B., Liu Y., Ekman P., Auer G., et al. Identification of two distinct deleted regions on chromosome 13 in prostate cancer. Oncogene 1998, 16:481-487.
101. Li Z., Tognon C.E., Godinho F.J., Yasaitis L., Hock H., Herschkowitz J.I., Lannon C.L., Cho E., Kim S.J., Bronson R.T., et al. ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell 2007, 12:542-558.
102. Lieber M.R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 2010, 79:181-211.
103. Lieber M.R., Gu J., Lu H., Shimazaki N., Tsai A.G. Nonhomologous DNA end joining (NHEJ) and chromosomal translocations in humans. Subcell. Biochem. 2010, 50:279-296.
104. Lieber M.R., Ma Y., Pannicke U., Schwarz K. Mechanism and regulation of human non-homologous DNA end-joining. Nat. Rev. Mol. Cell Biol. 2003, 4:712-720.
105. Liggett W.H., Sidransky D. Role of the p16 tumor suppressor gene in cancer. J. Clin. Oncol. 1998, 16:1197-1206.
106. Lin C., Yang L., Tanasa B., Hutt K., Ju B.G., Ohgi K., Zhang J., Rose D.W., Fu X.D., Glass C.K., et al. Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 2009, 139:1069-1083.
107. Lindahl T., Nyberg B. Heat-induced deamination of cytosine residues in deoxyribonucleic acid. Biochemistry 1974, 13:3405-3410.
108. Lindblom A., Sandelin K., Iselius L., Dumanski J., White I., Nordenskjold M., Larsson C. Predisposition for breast cancer in carriers of constitutional translocation 11q;22q. Am. J. Hum. Genet. 1994, 54:871-876.
109. Longerich S., Basu U., Alt F., Storb U. AID in somatic hypermutation and class switch recombination. Curr. Opin. Immunol. 2006, 18:164-174.
110. Lonnig W.E., Saedler H. Chromosome rearrangements and transposable elements. Annu. Rev. Genet. 2002, 36:389-410.
111. Mackie Ogilvie C., Scriven P.N. Meiotic outcomes in reciprocal translocation carriers ascertained in 3-day human embryos. Eur. J. Hum. Genet. 2002, 10:801-806.
112. Magi-Galluzzi C., Tsusuki T., Elson P., Simmerman K., LaFargue C., Esgueva R., Klein E., Rubin M.A., Zhou M. TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients. Prostate 2011, 71:489-497.
113. Maher C.A., Palanisamy N., Brenner J.C., Cao X., Kalyana-Sundaram S., Luo S., Khrebtukova I., Barrette T.R., Grasso C., Yu J., et al. Chimeric transcript discovery by paired-end transcriptome sequencing. Proc. Natl. Acad. Sci. USA 2009, 106:12353-12358.
114. Mani R.S., Chinnaiyan A.M. Triggers for genomic rearrangements: insights into genomic, cellular and environmental influences. Nat. Rev. Genet. 2010, 11:819-829.
115. Mani R.S., Iyer M.K., Cao Q., Brenner J.C., Wang L., Ghosh A., Cao X., Lonigro R.J., Tomlins S.A., Varambally S., et al. TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers. Cancer Res. 2011, 71:5387-5392.
116. Mani R.S., Tomlins S.A., Callahan K., Ghosh A., Nyati M.K., Varambally S., Palanisamy N., Chinnaiyan A.M. Induced chromosomal proximity and gene fusions in prostate cancer. Science 2009, 326:1230.
117. Mao X., Shaw G., James S.Y., Purkis P., Kudahetti S.C., Tsigani T., Kia S., Young B.D., Oliver R.T., Berney D., et al. Detection of TMPRSS2:ERG fusion gene in circulating prostate cancer cells. Asian J. Androl. 2008, 10:467-473.
118. Marians K.J. Replication and recombination intersect. Curr. Opin. Genet. Dev. 2000, 10:151-156.
119. Martin S.L., Bushman F.D. Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon. Mol. Cell. Biol. 2001, 21:467-475.
120. Masse E., Drolet M. R-loop-dependent hypernegative supercoiling in Escherichia coli topA mutants preferentially occurs at low temperatures and correlates with growth inhibition. J. Mol. Biol. 1999, 294:321-332.
121. Mateos-Langerak J., Goetze S., Leonhardt H., Cremer T., van Driel R., Lanctot C. Nuclear architecture: is it important for genome function and can we prove it?. J. Cell. Biochem. 2007, 102:1067-1075.
122. Mathias S.L., Scott A.F., Kazazian H.H., Boeke J.D., Gabriel A. Reverse transcriptase encoded by a human transposable element. Science 1991, 254:1808-1810.
123. McCord J.M., Fridovich I. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen. J. Biol. Chem. 1969, 244:6056-6063.
124. Meaburn K.J., Misteli T. Cell biology: chromosome territories. Nature 2007, 445:379-781.
125. Meaburn K.J., Misteli T., Soutoglou E. Spatial genome organization in the formation of chromosomal translocations. Semin. Cancer Biol. 2007, 17:80-90.
126. Medema R.H., Macurek L. Checkpoint control and cancer. Oncogene 2011.
127. Mehra R., Han B., Tomlins S.A., Wang L., Menon A., Wasco M.J., Shen R., Montie J.E., Chinnaiyan A.M., Shah R.B. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Cancer Res. 2007, 67:7991-7995.
128. Misteli T. Spatial positioning: a new dimension in genome function. Cell 2004, 119:153-156.
129. Misteli T. Concepts in nuclear architecture. Bioessays 2005, 27:477-487.
130. Misteli T. Cell biology: nuclear order out of chaos. Nature 2008, 456:333-334.
131. Misteli T. Self-organization in the genome. Proc. Natl. Acad. Sci. USA 2009, 106:6885-6886.
132. Misteli T., Soutoglou E. The emerging role of nuclear architecture in DNA repair and genome maintenance. Nat. Rev. Mol. Cell Biol. 2009, 10:243-254.
133. Mistry A.R., Felix C.A., Whitmarsh R.J., Mason A., Reiter A., Cassinat B., Parry A., Walz C., Wiemels J.L., Segal M.R., et al. DNA topoisomerase II in therapy-related acute promyelocytic leukemia. N. Engl. J. Med. 2005, 352:1529-1538.
134. Mitelman F., Johansson B., Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 2007, 7:233-245.
135. Modesti M., Kanaar R. Homologous recombination: from model organisms to human disease. Genome Biol. 2001, 2. REVIEWS1014.
136. Morrish T.A., Gilbert N., Myers J.S., Vincent B.J., Stamato T.D., Taccioli G.E., Batzer M.A., Moran J.V. DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat. Genet. 2002, 31:159-165.
137. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
138. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., Honjo T. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 1999, 274:18470-18476.
139. Murmann A.E., Gao J., Encinosa M., Gautier M., Peter M.E., Eils R., Lichter P., Rowley J.D. Local gene density predicts the spatial position of genetic loci in the interphase nucleus. Exp. Cell Res. 2005, 311:14-26.
140. Myung K., Chen C., Kolodner R.D. Multiple pathways cooperate in the suppression of genome instability in Saccharomyces cerevisiae. Nature 2001, 411:1073-1076.
141. Nambiar M., Raghavan S.C. How does DNA break during chromosomal translocations?. Nucleic Acids Res. 2011, 39:5813-5825.
142. Nelson D.L., Gibbs R.A. Genetics. The critical region in trisomy 21. Science 2004, 306:619-621.
143. Nemec A.A., Wallace S.S., Sweasy J.B. Variant base excision repair proteins: contributors to genomic instability. Semin. Cancer Biol. 2010, 20:320-328.
144. Nowell P.C. Discovery of the Philadelphia chromosome: a personal perspective. J. Clin. Invest. 2007, 117:2033-2035.
145. Nussenzweig A., Nussenzweig M.C. Origin of chromosomal translocations in lymphoid cancer. Cell 2010, 141:27-38.
146. Ohka F., Natsume A., Motomura K., Kishida Y., Kondo Y., Abe T., Nakasu Y., Namba H., Wakai K., Fukui T., et al. The global DNA methylation surrogate LINE-1 methylation is correlated with MGMT promoter methylation and is a better prognostic factor for glioma. PLoS One 2011, 6:e23332.
147. Oliver-Bonet M., Navarro J., Carrera M., Egozcue J., Benet J. Aneuploid and unbalanced sperm in two translocation carriers: evaluation of the genetic risk. Mol. Hum. Reprod. 2002, 8:958-963.
148. Ostertag E.M., Kazazian H.H. Biology of mammalian L1 retrotransposons. Annu. Rev. Genet. 2001, 35:501-538.
149. Palanisamy N., Ateeq B., Kalyana-Sundaram S., Pflueger D., Ramnarayanan K., Shankar S., Han B., Cao Q., Cao X., Suleman K., et al. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat. Med. 2010, 16:793-798.
150. Parada L.A., McQueen P.G., Misteli T. Tissue-specific spatial organization of genomes. Genome Biol. 2004, 5:R44.
151. Petersen-Mahrt S.K., Harris R.S., Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 2002, 418:99-103.
152. Pierotti M.A., Santoro M., Jenkins R.B., Sozzi G., Bongarzone I., Grieco M., Monzini N., Miozzo M., Herrmann M.A., Fusco A., et al. Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC. Proc. Natl. Acad. Sci. USA 1992, 89:1616-1620.
153. Pogribny I., Raiche J., Slovack M., Kovalchuk O. Dose-dependence, sex- and tissue-specificity, and persistence of radiation-induced genomic DNA methylation changes. Biochem. Biophys. Res. Commun. 2004, 320:1253-1261.
154. Pollack J.R., Perou C.M., Alizadeh A.A., Eisen M.B., Pergamenschikov A., Williams C.F., Jeffrey S.S., Botstein D., Brown P.O. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat. Genet. 1999, 23:41-46.
155. Powell S.N., Kachnic L.A. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene 2003, 22:5784-5791.
156. Prado F., Aguilera A. Impairment of replication fork progression mediates RNA polII transcription-associated recombination. EMBO J. 2005, 24:1267-1276.
157. Rabbitts T.H. Chromosomal translocations in human cancer. Nature 1994, 372:143-149.
158. Rada C., Williams G.T., Nilsen H., Barnes D.E., Lindahl T., Neuberger M.S. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Curr. Biol. 2002, 12:1748-1755.
159. Ragu S., Faye G., Iraqui I., Masurel-Heneman A., Kolodner R.D., Huang M.E. Oxygen metabolism and reactive oxygen species cause chromosomal rearrangements and cell death. Proc. Natl. Acad. Sci. USA 2007, 104:9747-9752.
160. Ramiro A.R., Nussenzweig M.C., Nussenzweig A. Switching on chromosomal translocations. Cancer Res. 2006, 66:7837-7839.
161. Ramiro A.R., Stavropoulos P., Jankovic M., Nussenzweig M.C. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat. Immunol. 2003, 4:452-456.
162. Ramsden D.A., Weed B.D., Reddy Y.V. V(D)J recombination: born to be wild. Semin. Cancer Biol. 2010, 20:254-260.
163. Rao P.H., Cigudosa J.C., Ning Y., Calasanz M.J., Iida S., Tagawa S., Michaeli J., Klein B., Dalla-Favera R., Jhanwar S.C., et al. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma. Blood 1998, 92:1743-1748.
164. Rassool F.V., Gaymes T.J., Omidvar N., Brady N., Beurlet S., Pla M., Reboul M., Lea N., Chomienne C., Thomas N.S., et al. Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?. Cancer Res. 2007, 67:8762-8771.
165. Ren R. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat. Rev. Cancer 2005, 5:172-183.
166. Robbiani D.F., Bunting S., Feldhahn N., Bothmer A., Camps J., Deroubaix S., McBride K.M., Klein I.A., Stone G., Eisenreich T.R., et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol. Cell 2009, 36:631-641.
167. Rosti G., Castagnetti F., Gugliotta G., Palandri F., Baccarani M. Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase. Crit. Rev. Oncol. Hematol. 2011.
168. Rowley J.D. Chromosomal patterns in myelocytic leukemia. N. Engl. J. Med. 1973, 289:220-221.
169. Rowley J.D. Chromosome translocations: dangerous liaisons revisited. Nat. Rev. Cancer 2001, 1:245-250.
170. Rudin C.M., Thompson C.B. Transcriptional activation of short interspersed elements by DNA-damaging agents. Genes Chromosomes Cancer 2001, 30:64-71.
171. Sandberg A.A., Yamada K. Chromosomes and causation of human cancer and leukemia. I. Karyotypic diversity in a single cancer. Cancer 1966, 19:1869-1878.
172. Schmitz K.J., Otterbach F., Callies R., Levkau B., Holscher M., Hoffmann O., Grabellus F., Kimmig R., Schmid K.W., Baba H.A. Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathological study of 99 cases. Mod. Pathol. 2004, 17:15-21.
173. Schoenfelder S., Clay I., Fraser P. The transcriptional interactome: gene expression in 3D. Curr. Opin. Genet. Dev. 2010, 20:127-133.
174. Schotta G., Sengupta R., Kubicek S., Malin S., Kauer M., Callen E., Celeste A., Pagani M., Opravil S., De La Rosa-Velazquez I.A., et al. A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse. Genes Dev. 2008, 22:2048-2061.
175. Schrock E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D., et al. Multicolor spectral karyotyping of human chromosomes. Science 1996, 273:494-497.
176. Shaffer D.R., Pandolfi P.P. Breaking the rules of cancer. Nat. Med. 2006, 12:14-15.
177. Shedge V., Davila J., Arrieta-Montiel M.P., Mohammed S., Mackenzie S.A. Extensive rearrangement of the Arabidopsis mitochondrial genome elicits cellular conditions for thermotolerance. Plant Physiol. 2010, 152:1960-1970.
178. Shimazaki N., Tsai A.G., Lieber M.R. H3K4me3 stimulates the V(D)J RAG complex for both nicking and hairpinning in trans in addition to tethering in cis: implications for translocations. Mol. Cell 2009, 34:535-544.
179. Shrivastav M., De Haro L.P., Nickoloff J.A. Regulation of DNA double-strand break repair pathway choice. Cell Res. 2008, 18:134-147.
180. Simsek D., Jasin M. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat. Struct. Mol. Biol. 2010, 17:410-416.
181. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
182. Skandalis A., Ford B.N., Glickman B.W. Strand bias in mutation involving 5-methylcytosine deamination in the human HPRT gene. Mutat. Res. 1994, 314:21-26.
183. Skok J.A., Brown K.E., Azuara V., Caparros M.L., Baxter J., Takacs K., Dillon N., Gray D., Perry R.P., Merkenschlager M., et al. Nonequivalent nuclear location of immunoglobulin alleles in B lymphocytes. Nat. Immunol. 2001, 2:848-854.
184. Slade I., Stephens P., Douglas J., Barker K., Stebbings L., Abbaszadeh F., Pritchard-Jones K., Cole R., Pizer B., Stiller C., et al. Constitutional translocation breakpoint mapping by genome-wide paired-end sequencing identifies HACE1 as a putative Wilms tumour susceptibility gene. J. Med. Genet. 2010, 47:342-347.
185. Slotkin R.K., Martienssen R. Transposable elements and the epigenetic regulation of the genome. Nat. Rev. Genet. 2007, 8:272-285.
186. Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., Fujiwara S., Watanabe H., Kurashina K., Hatanaka H., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
187. Sohail A., Klapacz J., Samaranayake M., Ullah A., Bhagwat A.S. Human activation-induced cytidine deaminase causes transcription-dependent, strand-biased C to U deaminations. Nucleic Acids Res. 2003, 31:2990-2994.
188. Speicher M.R., Carter N.P. The new cytogenetics: blurring the boundaries with molecular biology. Nat. Rev. Genet. 2005, 6:782-792.
189. Spilianakis C.G., Lalioti M.D., Town T., Lee G.R., Flavell R.A. Interchromosomal associations between alternatively expressed loci. Nature 2005, 435:637-645.
190. Srivatsan A., Tehranchi A., MacAlpine D.M., Wang J.D. Co-orientation of replication and transcription preserves genome integrity. PLoS Genet. 2010, 6:e1000810.
191. Stavnezer J., Guikema J.E., Schrader C.E. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 2008, 26:261-292.
192. Stern C. Boveri and the early days of genetics. Nature 1950, 166:446.
193. Sunami E., de Maat M., Vu A., Turner R.R., Hoon D.S. LINE-1 hypomethylation during primary colon cancer progression. PLoS One 2011, 6:e18884.
194. Takizawa T., Meaburn K.J., Misteli T. The meaning of gene positioning. Cell 2008, 135:9-13.
195. Taub R., Kirsch I., Morton C., Lenoir G., Swan D., Tronick S., Aaronson S., Leder P. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc. Natl. Acad. Sci. USA 1982, 79:7837-7841.
196. Tehranchi A.K., Blankschien M.D., Zhang Y., Halliday J.A., Srivatsan A., Peng J., Herman C., Wang J.D. The transcription factor DksA prevents conflicts between DNA replication and transcription machinery. Cell 2010, 141:595-605.
197. Tognon C., Knezevich S.R., Huntsman D., Roskelley C.D., Melnyk N., Mathers J.A., Becker L., Carneiro F., MacPherson N., Horsman D., et al. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2002, 2:367-376.
198. Tomlins S.A., Laxman B., Dhanasekaran S.M., Helgeson B.E., Cao X., Morris D.S., Menon A., Jing X., Cao Q., Han B., et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007, 448:595-599.
199. Tomlins S.A., Rhodes D.R., Perner S., Dhanasekaran S.M., Mehra R., Sun X.W., Varambally S., Cao X., Tchinda J., Kuefer R., et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005, 310:644-648.
200. Trautinger B.W., Jaktaji R.P., Rusakova E., Lloyd R.G. RNA polymerase modulators and DNA repair activities resolve conflicts between DNA replication and transcription. Mol. Cell 2005, 19:247-258.
201. Trigueros S., Roca J. Circular minichromosomes become highly recombinogenic in topoisomerase-deficient yeast cells. J. Biol. Chem. 2001, 276:2243-2248.
202. Tsai A.G., Lu H., Raghavan S.C., Muschen M., Hsieh C.L., Lieber M.R. Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity. Cell 2008, 135:1130-1142.
203. Turner D.P., Watson D.K. ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev. Anticancer Ther. 2008, 8:33-42.
204. van der Burg M., Poulsen T.S., Hunger S.P., Beverloo H.B., Smit E.M., Vang-Nielsen K., Langerak A.W., van Dongen J.J. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia. Leukemia 2004, 18:895-908.
205. Varella-Garcia M. Molecular cytogenetics in solid tumors: laboratorial tool for diagnosis, prognosis, and therapy. Oncologist 2003, 8:45-58.
206. Vilain A., Bernardino J., Gerbault-Seureau M., Vogt N., Niveleau A., Lefrancois D., Malfoy B., Dutrillaux B. DNA methylation and chromosome instability in lymphoblastoid cell lines. Cytogenet. Cell Genet. 2000, 90:93-101.
207. Vilette D., Ehrlich S.D., Michel B. Transcription-induced deletions in Escherichia coli plasmids. Mol. Microbiol. 1995, 17:493-504.
208. Voelkel-Meiman K., Keil R.L., Roeder G.S. Recombination-stimulating sequences in yeast ribosomal DNA correspond to sequences regulating transcription by RNA polymerase I. Cell 1987, 48:1071-1079.
209. Wai D.H., Knezevich S.R., Lucas T., Jansen B., Kay R.J., Sorensen P.H. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells. Oncogene 2000, 19:906-915.
210. Walsh C.P., Chaillet J.R., Bestor T.H. Transcription of IAP endogenous retroviruses is constrained by cytosine methylation. Nat. Genet. 1998, 20:116-117.
211. Wang J., Cai Y., Ren C., Ittmann M. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. Cancer Res. 2006, 66:8347-8351.
212. Washburn R.S., Gottesman M.E. Transcription termination maintains chromosome integrity. Proc. Natl. Acad. Sci. USA 2011, 108:792-797.
213. Weinstock D.M., Brunet E., Jasin M. Induction of chromosomal translocations in mouse and human cells using site-specific endonucleases. J. Natl. Cancer Inst. Monogr. 2008, (39):20-24.
214. Westover K.D., Bushnell D.A., Kornberg R.D. Structural basis of transcription: separation of RNA from DNA by RNA polymerase II. Science 2004, 303:1014-1016.
215. Wieland I., Muschke P., Volleth M., Ropke A., Pelz A.F., Stumm M., Wieacker P. High incidence of familial breast cancer segregates with constitutional t(11;22)(q23;q11). Genes Chromosomes Cancer 2006, 45:945-949.
216. Wilhelm C.S., Kelsey K.T., Butler R., Plaza S., Gagne L., Zens M.S., Andrew A.S., Morris S., Nelson H.H., Schned A.R., et al. Implications of LINE1 methylation for bladder cancer risk in women. Clin. Cancer Res. 2010, 16:1682-1689.
217. Williamson M.P., Elder P.A., Shaw M.E., Devlin J., Knowles M.A. p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum. Mol. Genet. 1995, 4:1569-1577.
218. Wong S., Witte O.N. The BCR-ABL story: bench to bedside and back. Annu. Rev. Immunol. 2004, 22:247-306.
219. Wu H.Y., Shyy S.H., Wang J.C., Liu L.F. Transcription generates positively and negatively supercoiled domains in the template. Cell 1988, 53:433-440.
220. Xu G.L., Bestor T.H., Bourc'his D., Hsieh C.L., Tommerup N., Bugge M., Hulten M., Qu X., Russo J.J., Viegas-Pequignot E. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999, 402:187-191.
221. Yoder J.A., Walsh C.P., Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 1997, 13:335-340.
222. Yoshimoto M., Joshua A.M., Chilton-Macneill S., Bayani J., Selvarajah S., Evans A.J., Zielenska M., Squire J.A. Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement. Neoplasia 2006, 8:465-469.
223. Yoshimoto M., Joshua A.M., Cunha I.W., Coudry R.A., Fonseca F.P., Ludkovski O., Zielenska M., Soares F.A., Squire J.A. Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome. Mod. Pathol. 2008, 21:1451-1460.
224. Zhang F., Carvalho C.M., Lupski J.R. Complex human chromosomal and genomic rearrangements. Trends Genet. 2009, 25:298-307.
225. Zhang Y., Gostissa M., Hildebrand D.G., Becker M.S., Boboila C., Chiarle R., Lewis S., Alt F.W. The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers. Adv. Immunol. 2010, 106:93-133.
226. Zhao R., Bodnar M.S., Spector D.L. Nuclear neighborhoods and gene expression. Curr. Opin. Genet. Dev. 2009, 19:172-179.